- Home
- MGIH vs COSM Comparison
MGIH vs COSM Comparison
Compare MGIH & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIH
- COSM
- Stock Information
- Founded
- MGIH 1978
- COSM 2009
- Country
- MGIH Hong Kong
- COSM United States
- Employees
- MGIH N/A
- COSM N/A
- Industry
- MGIH Publishing
- COSM Other Pharmaceuticals
- Sector
- MGIH Consumer Discretionary
- COSM Health Care
- Exchange
- MGIH Nasdaq
- COSM Nasdaq
- Market Cap
- MGIH 20.5M
- COSM 18.4M
- IPO Year
- MGIH 2023
- COSM 2013
- Fundamental
- Price
- MGIH $1.67
- COSM $0.62
- Analyst Decision
- MGIH
- COSM
- Analyst Count
- MGIH 0
- COSM 0
- Target Price
- MGIH N/A
- COSM N/A
- AVG Volume (30 Days)
- MGIH 55.0K
- COSM 397.6K
- Earning Date
- MGIH 10-30-2024
- COSM 11-14-2024
- Dividend Yield
- MGIH N/A
- COSM N/A
- EPS Growth
- MGIH N/A
- COSM N/A
- EPS
- MGIH N/A
- COSM N/A
- Revenue
- MGIH $38,530,773.00
- COSM $56,042,109.00
- Revenue This Year
- MGIH N/A
- COSM $4.53
- Revenue Next Year
- MGIH N/A
- COSM $25.00
- P/E Ratio
- MGIH N/A
- COSM N/A
- Revenue Growth
- MGIH N/A
- COSM 13.01
- 52 Week Low
- MGIH $1.19
- COSM $0.47
- 52 Week High
- MGIH $6.83
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- MGIH 50.94
- COSM 40.41
- Support Level
- MGIH $1.47
- COSM $0.60
- Resistance Level
- MGIH $1.64
- COSM $0.67
- Average True Range (ATR)
- MGIH 0.21
- COSM 0.07
- MACD
- MGIH -0.01
- COSM -0.01
- Stochastic Oscillator
- MGIH 29.85
- COSM 6.77
About MGIH Millennium Group International Holdings Limited
Millennium Group International Holdings Ltd is a paper-based packaging solutions supplier. It offers paper-based inner and outer packaging products which can be broadly categorized into packaging products, Packaging products supply chain management solutions and corrugated products.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.